Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-05 Sale | 2022-08-09 6:38 pm | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 9,089 | $155.44 | $1,412,797 | 11,871 (Direct) | View |
| 2021-12-06 Purchase | 2021-12-08 4:16 pm | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO | 100,000 | $2.23 | $223,000 | 1,355,873 (Indirect Direct) | View |
| 2021-08-06 Sale | 2021-08-10 5:38 pm | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 1,306 | $147.96 | $193,236 | 10,399 (Direct) | View |
| 2020-08-06 Sale | 2020-08-10 4:50 pm | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 931 | $125.87 | $117,186 | 16,224 (Direct) | View |
| 2020-01-10 Purchase | 2020-01-14 4:23 pm | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO and President | 35,000 | $3 | $105,000 | 1,003,147 (Indirect Direct) | View |
| 2019-08-08 Sale | 2019-08-12 5:32 pm | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 726 | $135.65 | $98,482 | 12,490 (Direct) | View |
| 2018-11-15 Purchase | 2018-11-15 7:10 pm | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 5,000 | $6 | $30,000 | 59,745 (Direct) | View |
| 2018-08-09 Sale | 2018-08-13 7:57 pm | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 660 | $176.61 | $116,563 | 10,226 (Direct) | View |
| 2018-06-25 Purchase | 2018-06-26 4:44 pm | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO and President | 2,400 | $16 | $38,400 | 929,584 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-03 Option Award | 2023-01-05 4:17 pm | N/A 2033-01-02 | Aptinyx Inc. | APTX | RIEDEL NORBERT G EXECUTIVE CHAIRMAN OF THE BOD | 420,000 | $0 | 420,000 (Direct) | View |
| 2022-08-05 Exercise | 2022-08-09 6:38 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 8,000 | $55.28 | 11,871 (Direct) | View |
| 2022-08-05 Option Award | 2022-08-09 6:38 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 2,561 | $0 | 11,871 (Direct) | View |
| 2022-08-05 Exercise | 2022-08-09 6:38 pm | N/A 2023-05-08 | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 8,000 | $0 | 11,871 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:49 pm | N/A 2032-06-14 | Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director | 23,459 | $0 | 23,459 (Direct) | View |
| 2022-02-07 Option Award | 2022-02-28 4:34 pm | N/A 2032-02-07 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 50,000 | $0 | 109,555 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-06 4:31 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director | 14,270 | $0 | 42,810 (Direct) | View |
| 2021-12-02 Option Award | 2021-12-07 4:16 pm | N/A 2031-12-01 | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO | 475,000 | $0 | 475,000 (Direct) | View |
| 2021-07-29 Option Award | 2021-08-02 6:25 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 2,246 | $0 | 11,705 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:14 pm | N/A 2031-06-10 | Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director | 58,003 | $0 | 58,003 (Direct) | View |
| 2021-05-17(A) Tax Withholding | 2021-05-20 5:53 pm | N/A N/A | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO | 127,274 | $2.53 | 1,255,873 (Direct) | View |
| 2021-05-17(A) Exercise | 2021-05-20 5:53 pm | N/A N/A | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO | 380,000 | $0 | 1,255,873 (Direct) | View |
| 2021-05-17 Tax Withholding | 2021-05-19 6:46 pm | N/A N/A | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO | 127,274 | $2.53 | 615,265 (Direct) | View |
| 2021-05-17 Exercise | 2021-05-19 6:46 pm | N/A N/A | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO | 380,000 | $0 | 615,265 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 4:15 pm | N/A 2031-05-03 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 19,655 | $0 | 59,555 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 7:34 pm | N/A 2031-02-23 | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO | 733,300 | $0 | 733,300 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-06 4:26 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director | 14,270 | $0 | 42,810 (Direct) | View |
| 2020-10-27 Ownership | 2020-10-30 7:51 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director | 0 | $0 | 42,810 (Direct) | View |
| 2020-08-06 Option Award | 2020-08-10 4:50 pm | N/A 2030-08-05 | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 9,470 | $0 | 16,224 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-16 4:52 pm | N/A 2030-03-11 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 27,400 | $0 | 27,400 (Direct) | View |
| 2020-02-26 Option Award | 2020-02-28 4:34 pm | N/A 2030-02-25 | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO and President | 625,000 | $0 | 625,000 (Direct) | View |
| 2019-08-08 Option Award | 2019-08-12 5:32 pm | N/A 2029-08-07 | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 6,725 | $0 | 12,490 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-17 7:01 pm | N/A N/A | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO and President | 380,000 | $0 | 380,000 (Direct) | View |
| 2019-02-20 Option Award | 2019-03-08 4:35 pm | N/A 2029-02-19 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-07 4:26 pm | N/A 2029-01-03 | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO and President | 275,000 | $0 | 275,000 (Direct) | View |
| 2018-11-12 Exercise | 2018-11-14 4:16 pm | N/A N/A | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO and President | 38,563 | $2.59 | 1,409,762 (Direct) | View |
| 2018-11-12 Exercise | 2018-11-14 4:16 pm | N/A 2027-02-01 | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO and President | 38,563 | $0 | 1,409,762 (Direct) | View |
| 2018-11-09 Ownership | 2018-11-13 5:13 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 0 | $0 | 79,745 (Direct) | View |
| 2018-09-20 Option Award | 2018-09-21 4:17 pm | N/A 2028-09-19 | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO and President | 427,265 | $0 | 427,265 (Direct) | View |
| 2018-08-09 Option Award | 2018-08-13 7:57 pm | N/A 2028-08-08 | Jazz Pharmaceuticals plc | JAZZ | RIEDEL NORBERT G Director | 5,230 | $0 | 10,226 (Direct) | View |
| 2018-06-25 Conversion | 2018-06-26 4:44 pm | N/A N/A | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO and President | 3,407,476 | $0 | 929,584 (Direct) | View |
| 2018-06-20 Ownership | 2018-06-20 7:38 pm | N/A N/A | Aptinyx Inc. | APTX | RIEDEL NORBERT G CEO and President | 0 | $0 | 1,987,692 (Direct) | View |